News & Insights

Emergent Bioservices News, Insights & Events

Stay informed with news, insightful thought leadership, featured articles and engaging content from Emergent Bioservices and check out what events we’ll be attending throughout the year.

10.27.2022

SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions

SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...

10.04.2022

Focus on Fill and Finish

Kelly Christiansen, vice president & general manager of Emergent CDMO's Rockville drug product manufacturing facility recently...

09.01.2022

EXECUTIVE INTERVIEW – Emergent CDMO: A Molecule-to-Market Partner for Complex Biologics

For nearly 25 years, Emergent has developed, manufactured, and delivered their own innovative vaccines and biotherapeutic...

08.17.2022

How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology and Vaccines

Nanoparticles have experienced increasing demand in recent years in biopharmaceutical formulations, owing to their utility for...

04.14.2022

Molecule to Market: Inside the Outsourcing Space

Emergent recently had the pleasure of participating in the Molecule to Market Podcast hosted by Ramen Sehgal from from ra...

03.21.2022

Four Key Considerations to Help Prepare for the Next Public Health Threat

As a CDMO, Emergent has been working for more than two decades to develop, manufacture, and deliver protections against public...